These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 8495233)

  • 1. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction of lacidipine with calcium channels in vascular smooth muscle.
    Godfraind T; Salomone S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S1-6. PubMed ID: 1725443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
    Morel N; Godfraind T
    Br J Pharmacol; 1991 Feb; 102(2):467-77. PubMed ID: 1826619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AE0047-mediated calcium channel blocking in vascular smooth muscles.
    Yamanaga K; Shinyama H; Akira T; Iwamoto M; Uchida T; Nakamura N; Kagitani Y
    Gen Pharmacol; 1997 Sep; 29(3):337-43. PubMed ID: 9378237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding sites for 1,4-dihydropyridine Ca(2+)-channel modulators in rat intestinal smooth muscle.
    Salomone S; Wibo M; Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):698-705. PubMed ID: 1837846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain.
    Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):442-51. PubMed ID: 2555723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
    Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
    Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the presence of regional differences in the calcium antagonist receptors in lower urinary tract smooth muscle.
    Latifpour J; Yoshida M; Weiss RM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jun; 345(6):679-87. PubMed ID: 1386146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dihydropyridine receptor density in vasa deferentia of castrated rats.
    Castillo CJ; Lafayette S; Caricati-Neto A; Sette M; Jurkiewicz NH; García AG; Jurkiewicz A
    Br J Pharmacol; 1992 Feb; 105(2):257-8. PubMed ID: 1313721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of lacidipine with its receptor binding site supports a slow onset and long duration of action.
    Graziani F; Ratti E; van Amsterdam FT
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):290-6. PubMed ID: 8720430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
    Zheng W; Hawthorn M; Triggle DJ
    Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta.
    Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
    Jpn J Pharmacol; 1991 Nov; 57(3):337-48. PubMed ID: 1667534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel.
    El Bardai S; Hamaide MC; Lyoussi B; Quetin-Leclercq J; Morel N; Wibo M
    Eur J Pharmacol; 2004 May; 492(2-3):269-72. PubMed ID: 15178374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine.
    Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E
    J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of Ca2+ channels in smooth muscle.
    Mironneau J
    Z Kardiol; 1991; 80 Suppl 7():43-6. PubMed ID: 1665262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells.
    Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG
    J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.